Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 6/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.40 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.38 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30497683 | 1.00 | TSHR (0.44) | TSHRTHRBZDHHC20ZDHHC2ALDH1A1 | |
| SCHEMBL30497681 | 1.00 | TSHR (0.44) | TSHRTHRBZDHHC20ZDHHC2ALDH1A1 | |
| SCHEMBL30497682 | 1.00 | TSHR (0.44) | TSHRTHRBZDHHC20ZDHHC2ALDH1A1 | |
| SCHEMBL10824855 | 1.00 | TSHR (0.44) | TSHRTHRBZDHHC20ZDHHC2ALDH1A1 | |
| SCHEMBL7212251 | 1.00 | TSHR (0.44) | TSHRTHRBZDHHC20ZDHHC2ALDH1A1 | |
| SCHEMBL25241378 | 1.00 | TSHR (0.44) | TSHRTHRBZDHHC20ZDHHC2ALDH1A1 | |
| SCHEMBL4521741 | 1.00 | TSHR (0.44) | TSHRTHRBZDHHC20ZDHHC2ALDH1A1 | |
| SCHEMBL6567469 | 0.97 | TSHR (0.40) | TSHRTHRBZDHHC20ZDHHC2ALDH1A1 | |
| SCHEMBL3319053 | 0.90 | — | — | |
| SCHEMBL6909579 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4212494-B1 | POLYMER HAVING DISPERSING FUNCTION AND USE THEREOF | CHINA PETROLEUM & CHEM CORP (CN) | 2026-05-06 | — | — | EP | disclosed |
| US-20230391941-A1 | POLYMER HAVING DISPERSING FUNCTION, POLYCARBOXYLIC ACID CEMENT DISPERSANT, PREPARATION METHOD THEREFOR AND USE THEREOF | CHINA PETROLEUM & CHEMICAL CORPORATION (CN) | 2023-12-07 | — | — | US | disclosed |
| US-20230387464-A1 | Nonaqueous Electrolytic Solution and Nonaqueous Electrolytic Solution Battery | MU IONIC SOLUTIONS CORPORATION (JP) | 2023-11-30 | — | — | US | disclosed |
| EP-4212494-A1 | POLYMER HAVING DISPERSING FUNCTION, POLYCARBOXYLIC ACID CEMENT DISPERSANT, PREPARATION METHOD THEREFOR AND USE THEREOF | China Petroleum & Chemical Corporation (CN) | 2023-07-19 | — | — | EP | disclosed |
| US-8314051-B2 | Method of preparing 1-methylcyclopropene and applying the same to plants | ERUM BIOTECHNOLOGIES INC. (KR) | 2012-11-20 | — | — | US | disclosed |
| US-20100076242-A1 | METHOD OF PREPARING 1-METHYLCYCLOPROPENE AND APPLYING THE SAME TO PLANTS | JANSSEN PHARMACEUTICA NV (BE) | 2010-03-25 | — | — | US | disclosed |
| US-7083984-B2 | Hybrid phthalocyanine derivatives and their uses | BIOSITE, INC. (US) | 2006-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100076242-A1 | METHOD OF PREPARING 1-METHYLCYCLOPROPENE AND APPLYING THE SAME TO PLANTS | CHRM1, EMC1, CHRM2 | TSHR 122/4885THRB 2116/4885ZDHHC20 3872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.